MA
PFE icon

MYDA Advisors’s Pfizer PFE Stock Holding History

MYDA Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-100,000
Closed -$2.42M – 203
2025
Q2 		$2.42M Buy
+100,000
New +$2.33M 0.42% 63
2024
Q4 		– Sell
-140,000
Closed -$4.05M – 184
2024
Q3 		$4.05M Buy
140,000
+68,000
+94% +$1.98M 0.89% 35
2024
Q2 		$2.01M Sell
72,000
-28,000
-28% -$771K 0.44% 57
2024
Q1 		$2.77M Buy
100,000
+70,000
+233% +$1.94M 0.79% 36
2023
Q4 		$864K Buy
+30,000
New +$907K 0.29% 57
2021
Q3 		– Sell
-25,000
Closed -$979K – 296
2021
Q2 		$979K Buy
+25,000
New +$972K 0.24% 125
2020
Q4 		– Sell
-16,864
Closed -$587K – 222
2020
Q3 		$587K Buy
+16,864
New +$591K 0.3% 69

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

MYDA Advisors's PFE Position: Q3 2025 in Review

MYDA Advisors sold out of Pfizer (PFE) in Q3 2025, closing a stake of 100,000 shares — an estimated $2.42M sold.

MYDA Advisors first reported a position in PFE in Q3 2020 and held it in 7 quarters. The position peaked at $4.05M in Q3 2024. 2,811 funds tracked by Wall St. Rank hold PFE as of Q3 2025.

  • MYDA Advisors reported no remaining Pfizer position as of Q3 2025 after selling out during the quarter.
  • MYDA Advisors sold 100,000 Pfizer shares in Q3 2025, an estimated $2.42M.
  • MYDA Advisors first reported a position in Pfizer in Q3 2020 and held it in 7 quarters.
  • MYDA Advisors's Pfizer position peaked at $4.05M in Q3 2024.
  • 2,811 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.

Based on MYDA Advisors's 13F filing for Q3 2025, filed 13 Nov 2025.